Tejara Capital Ltd Purchases Shares of 100,378 electroCore, Inc. $ECOR

Tejara Capital Ltd acquired a new position in shares of electroCore, Inc. (NASDAQ:ECOR) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 100,378 shares of the company’s stock, valued at approximately $450,000. Tejara Capital Ltd owned 1.25% of electroCore as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. NewEdge Advisors LLC lifted its holdings in shares of electroCore by 857.9% during the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after acquiring an additional 145,047 shares in the last quarter. Jane Street Group LLC increased its holdings in electroCore by 114.4% in the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after purchasing an additional 19,599 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new stake in electroCore in the 1st quarter valued at $153,000. Two Sigma Investments LP raised its position in electroCore by 20.8% in the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after purchasing an additional 4,231 shares during the period. Finally, International Assets Investment Management LLC raised its position in electroCore by 15.2% in the fourth quarter. International Assets Investment Management LLC now owns 88,720 shares of the company’s stock valued at $398,000 after purchasing an additional 11,700 shares during the period. Hedge funds and other institutional investors own 26.74% of the company’s stock.

Insiders Place Their Bets

In other electroCore news, Director Daniel S. Goldberger sold 16,072 shares of electroCore stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $6.02, for a total transaction of $96,753.44. Following the sale, the director directly owned 291,471 shares in the company, valued at $1,754,655.42. The trade was a 5.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 13.80% of the stock is currently owned by company insiders.

electroCore Price Performance

NASDAQ:ECOR opened at $6.43 on Friday. The firm has a 50-day moving average of $6.47 and a two-hundred day moving average of $5.93. The stock has a market cap of $53.37 million, a P/E ratio of -3.63 and a beta of 0.68. electroCore, Inc. has a 1-year low of $4.16 and a 1-year high of $8.64.

electroCore (NASDAQ:ECOR) last announced its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.59). electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%.The business had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.01 million. As a group, equities analysts expect that electroCore, Inc. will post -1.48 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ECOR shares. upgraded electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. HC Wainwright lowered their target price on electroCore from $25.00 to $18.00 and set a “buy” rating for the company in a research note on Monday, January 26th. Zacks Research upgraded electroCore from a “strong sell” rating to a “hold” rating in a report on Friday, March 27th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of electroCore in a research report on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, electroCore has a consensus rating of “Hold” and a consensus price target of $18.00.

electroCore Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.